Familial Adenomatous Polyposis | A Pipeline Analysis Report 2018 | Technavio

Technavio has announced their latest pipeline analysis report on
the familial
adenomatous polyposis market. The report includes a detailed
analysis of the pipeline molecules under investigation within the
defined data collection period to treat familial adenomatous polyposis.

This press release features multimedia. View the full release here:
https://www.businesswire.com/news/home/20180710005706/en/

Technavio has published a new report on the drug development pipeline for familial adenomatous polyposis, including a detailed study of the pipeline molecules. (Graphic: Business Wire)

This report by Technavio presents a detailed analysis of the market,
including regulatory framework, drug development strategies, recruitment
strategies, and key companies that are expected to play an essential
role in the growth of the market in the future.

THIS REPORT IS AVAILABLE AT A USD 1,000 DISCOUNT FOR A LIMITED TIME
ONLY: VIEW
MARKET SNAPSHOT BEFORE PURCHASING

Familial adenomatous polyposis: Market overview

Familial adenomatous polyposis (FAP) is an inherited disorder that
causes extra tissue formation in the colon or large intestine and later
forms cancer in the colon. FAP leads to the development of additional
tissues, known as polyps, in the large intestine that can also form in
the upper gastrointestinal tract, especially in the upper part of the
small intestine. FAP has to be treated in the early stages, or else it
becomes cancerous. The milder form of FAP is called attenuated familial
adenomatous polyposis (AFAP) wherein the growth of polyps is slow.

According to a senior market research analyst at Technavio, “In order
to develop a healthy pipeline, several companies are either forming
planned exclusive licensing agreements or are acquiring companies. For
instance, Tillotts Pharma entered into an exclusive agreement with
Cancer Prevention Pharmaceuticals to help them in developing and
commercializing the drug for the treatment of FAP in Europe, Japan, and
North America.”

Familial adenomatous polyposis: Segmentation
analysis

This pipeline analysis report segments the familial adenomatous
polyposis market based on therapies employed (monotherapy and
combination therapy), RoA (oral), therapeutic modality (small molecule
and RNA), targets (beta-catenin, casein kinase 1 alpha,
cyclooxygenase-2, and ornithine decarboxylase), MoA (beta-catenin
inhibitor, casin kinase 1 alpha agonist, cyclooxygenase-2 inhibitor,
immunosuppressant, and ornithine decarboxylase inhibitor), geographical
segmentation (the US, the UK, Spain, Netherlands, Germany, Canada, and
Belgium) and drugs under development (discovery, pre-clinical, phase I,
phase I/II, and phase III). It provides an in-depth analysis of the
prominent factors influencing the market, including drivers,
opportunities, trends, and industry-specific challenges.

LOOKING FOR MORE INFORMATION ON THIS MARKET? REQUEST
A FREE SAMPLE REPORT

Technavio’s sample reports are free of charge and contain multiple
sections of the report such as the market size and forecast, drivers,
challenges, trends, and more.

Some of the key topics covered in the report include:

Scope of the Report

Regulatory Framework

Drug Development Landscape

Drug Development Strategies

Recruitment Strategies

Key Companies

Discontinued or Dormant Molecules

About Technavio

Technavio
is a leading global technology research and advisory company. Their
research and analysis focuses on emerging market trends and provides
actionable insights to help businesses identify market opportunities and
develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists
of more than 10,000 reports and counting, covering 800 technologies,
spanning across 50 countries. Their client base consists of enterprises
of all sizes, including more than 100 Fortune 500 companies. This
growing client base relies on Technavio’s comprehensive coverage,
extensive research, and actionable market insights to identify
opportunities in existing and potential markets and assess their
competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team
at media@technavio.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20180710005706/en/

Leave a Comment